Companies / Netherlands
Akzo Nobel to Divest Pharma Division
February 2006 | Company Finance AlertDutch chemical firm Akzo Nobel is planning to float its pharmaceuticals division. The separate drugs division will be called Organon Biosciences, and reflects a perceived preference in the market for single entities rather than conglomerates. German chemicals firm BASF spun off its pharmaceuticals division in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
